Article Text

Download PDFPDF
Benznidazole-induced drug reaction with eosinophilia and systemic symptoms syndrome in a patient with human leucocyte antigen (HLA)-A*68
  1. Thais Lizondo López1,
  2. Javier Gil Lianes2,
  3. Arnau Torrent Rodríguez1,
  4. Rubén González-García1,
  5. Montserrat Tuset Creus1,
  6. Victoria Amat Samaranch2,
  7. Dolors Soy-Muner1,
  8. José Manuel Mascaró2
  1. 1Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain
  2. 2Dermatological Service, Hospital Clínic Barcelona, Barcelona, Spain
  1. Correspondence to Thais Lizondo López, Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain; tlizondo{at}clinic.cat

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe drug hypersensitivity reaction with potentially life-threatening consequences. It is characterised by fever, extensive maculopapular exanthema, lymph node enlargement, abnormal blood cell counts, and organ-related complications. Diagnosis can be challenging due to incomplete or non-specific symptoms, and it can sometimes manifest as a purely systemic disease. Discontinuation of the causative drug is essential. Treatment may involve corticosteroids and supportive care. Genetic screening for specific markers, such as human leucocyte antigen (HLA)-A*68, A11:01, and A29:02, can help identify individuals at risk for severe reactions to benznidazole, a drug used to treat Chagas disease. This case report describes the rarity and severity of DRESS syndrome, underscoring the potential benefit of genetic screening to prevent adverse reactions in patients with Chagas disease.

  • DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS
  • DERMATOLOGY
  • Pharmacovigilance
  • ALLERGY AND IMMUNOLOGY
  • PARASITOLOGY

Data availability statement

All data relevant to the study are included in the article.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article.

View Full Text